preprint · medRxiv

Acceptance of an Mpox Vaccine in the Democratic Republic of the Congo

Skylar Petrichko
Jason Kindrachuk
Christophe Luhata
Sydney Merritt
Didine Kaba
Nicole A. Hoff
Dalau Mukadi Nkamba
Michael Beya
Megan Halbrook
Handdy Kalengi
Leonard Kamba
Anne W. Rimoin

20241 citationOpen accessUniversité de Kinshasa (UNIKIN)

Abstract

ABSTRACT We report general acceptance of an mpox vaccine (61.0%) in the Democratic Republic of the Congo (n = 5226) with higher acceptance among healthcare workers and respondents in historic mpox-endemic regions. These data highlight the need for increased community engagement and sensitization before widespread deployment of mpox vaccines.

Research topics

Vaccine Coverage and Hesitancy
Poxvirus research and outbreaks
Zoonotic diseases and public health

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.1101/2024.08.15.24311971

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.